Literature DB >> 8390584

Hepatocellular carcinoma with portal tumor thrombus: analysis of factors determining prognosis.

T Fujii1, K Takayasu, Y Muramatsu, N Moriyama, F Wakao, T Kosuge, T Takayama, M Makuuchi, S Yamasaki, N Okazaki.   

Abstract

For 104 consecutive patients with hepatocellular carcinoma (HCC) with portal tumor thrombus (PTT) seen in the past nine years, prognostic factors were analyzed retrospectively using Cox's multivariate analysis. There was a significant difference in survival rate with hepatic functional reserve (Child classification, P = 0.005), type of treatment (surgical vs non-surgical treatment, P = 0.009) and PTT grade (P = 0.04). The survival rates for patients with Child's A (n 49) or Child's B (n 55) were 60.8 vs 20.0% at one year, 41.6 vs 9.1% at two years and 35.4 vs 5.5% at three years. The survival rates of patients with surgical (n 32) and non-surgical (n 72) therapy were 71.7 vs 25.0% at one year, 58.5 vs 9.4% at two years and 53.6 vs 4.7% at three years. Among patients with PTT grades in the third or lower order branch (Vp1, n 29), the second order branch (Vp2, n 32) and the first or portal vein trunk (Vp3, n 43), the one-year, two-year and three-year survival rates were 61.6, 43.8 and 20.9%; 47.1, 27.5 and 6.2% and 42.8, 27.5 and 0%, respectively. When analysis was focused on 32 patients with Child's A and PTT (Vp1 plus Vp2) with respect to treatment, the survival rates in the surgical (n 22) and nonsurgical (n 10) groups were 86.1 vs 70.0% at one year, 71.5 vs 30.0% at two years and 64.3 vs 20.0% at three years (P < 0.05), respectively. In HCC patients with PTT, surgery seems to be indicated where hepatic function is well preserved and the PTT is localized in a peripheral portal branch.

Entities:  

Mesh:

Year:  1993        PMID: 8390584

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  21 in total

1.  Pathological complete remission of advanced hepatocellular carcinoma with main portal vein tumor thrombosis by hepatic arterial infusion chemotherapy.

Authors:  Yong Gil Kim; Jong Ryul Eun; Tae Nyeun Kim; Heon Ju Lee; Jae Woon Kim; Jay Chun Chang; Sung Su Yun; Joon Hyuk Choi
Journal:  Gut Liver       Date:  2010-06-16       Impact factor: 4.519

2.  Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative study.

Authors:  Yong-Fa Zhang; Rong-Ping Guo; Ru-Hai Zou; Jing-Xian Shen; Wei Wei; Shao-Hua Li; Han-Yue OuYang; Hong-Bo Zhu; Li Xu; Xiang-Ming Lao; Ming Shi
Journal:  Eur Radiol       Date:  2015-09-22       Impact factor: 5.315

Review 3.  Surgical treatment of hepatocellular carcinoma: evidence-based outcomes.

Authors:  Shintaro Yamazaki; Tadatoshi Takayama
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

4.  Efficacy of postoperative transarterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma complicated by portal vein tumor thrombosis--a randomized study.

Authors:  Q Li; J Wang; Y Sun; Y L Cui; J T Juzi; H X Li; B Y Qian; X S Hao
Journal:  World J Surg       Date:  2006-11       Impact factor: 3.352

5.  The role of three-dimensional imaging in optimizing diagnosis, classification and surgical treatment of hepatocellular carcinoma with portal vein tumor thrombus.

Authors:  Xu-Biao Wei; Jie Xu; Nan Li; Ying Yu; Jie Shi; Wei-Xing Guo; Hong-Yan Cheng; Meng-Chao Wu; Wan-Yee Lau; Shu-Qun Cheng
Journal:  HPB (Oxford)       Date:  2015-11-17       Impact factor: 3.647

6.  Successful multimodality treatment for advanced hepatocellular carcinoma with tumor thrombosis of the main portal trunk: a case study.

Authors:  Yumi Kosaka; Tomokazu Kawaoka; Yutaro Ogawa; Kei Amioka; Kensuke Naruto; Yuki Yoshikawa; Yuwa Ando; Yosuke Suehiro; Kenji Yamaoka; Yasutoshi Fujii; Shinsuke Uchikawa; Atsushi Ono; Masami Yamauchi; Michio Imamura; Keigo Chosa; Kazuo Awai; Yasushi Nagata; Kazuaki Chayama; Hiroshi Aikata
Journal:  Clin J Gastroenterol       Date:  2021-07-21

7.  Surgical resection versus conformal radiotherapy combined with TACE for resectable hepatocellular carcinoma with portal vein tumor thrombus: a comparative study.

Authors:  Qing-he Tang; Ai-jun Li; Guang-ming Yang; Eric C H Lai; Wei-ping Zhou; Zhi-hao Jiang; Wan Yee Lau; Meng-chao Wu
Journal:  World J Surg       Date:  2013-06       Impact factor: 3.352

8.  Hepatic arterial infusion chemotherapy for hepatocellular carcinoma with portal vein tumor thrombosis.

Authors:  Yung-Chih Lai; Cheng-Yen Shih; Chin-Ming Jeng; Sien-Sing Yang; Jui-Ting Hu; Yung-Chuan Sung; Han-Ting Liu; Shaw-Min Hou; Chi-Hwa Wu; Tzen-Kwan Chen
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

9.  Comparison of coplanar and noncoplanar intensity-modulated radiation therapy and helical tomotherapy for hepatocellular carcinoma.

Authors:  Chen-Hsi Hsieh; Chia-Yuan Liu; Pei-Wei Shueng; Ngot-Swan Chong; Chih-Jen Chen; Ming-Jen Chen; Ching-Chung Lin; Tsang-En Wang; Shee-Chan Lin; Hung-Chi Tai; Hui-Ju Tien; Kuo-Hsin Chen; Li-Ying Wang; Yen-Ping Hsieh; David Y C Huang; Yu-Jen Chen
Journal:  Radiat Oncol       Date:  2010-05-23       Impact factor: 3.481

10.  Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis.

Authors:  Daichi Takizawa; Satoru Kakizaki; Naondo Sohara; Ken Sato; Hitoshi Takagi; Hirotaka Arai; Kenji Katakai; Akira Kojima; Yutaka Matsuzaki; Masatomo Mori
Journal:  Dig Dis Sci       Date:  2007-03-30       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.